Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EphB4 antagonists(Ephrin type-B receptor 4 antagonists), PDGFRβ inhibitors(Platelet-derived growth factor receptor beta inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urologic Neoplasms | Phase 1 | US | 20 May 2011 | |
Urologic Neoplasms | Phase 1 | IN | 20 May 2011 | |
Urologic Neoplasms | Phase 1 | US | 20 May 2011 | |
Colonic Cancer | Preclinical | US | 01 Sep 2010 | |
Ovarian Cancer | Preclinical | US | 01 Sep 2010 | |
RAS mutant Colorectal Cancer | Preclinical | US | 01 Sep 2010 | |
Advanced Malignant Solid Neoplasm | Preclinical | US | 01 Feb 2009 | |
Neoplasms | Discovery | - | - | |
Neoplasms | Discovery | - | - |
Phase 1/2 | 19 | (Pharmacokinetic Arm) | wufbeorcmh(pamnhtlwsm) = gerbcoujnw atiaunjagm (cwrfjckcde, hrceqqwyya - rdziqscqps) View more | - | 25 Sep 2014 | ||
(Pharmacodynamic Arm) | aocrckabxm(blbqqswofx) = pqnyhkopgc cvnhexxujx (cvovojntfp, ajmjsbctqp - znmtbsenas) View more | ||||||
Phase 1/2 | 18 | okboedxbqb(gypyraiygr) = mnzdltylru dlnuxmthma (lbelxiwzze, effuvzqrsk - nfhbmbpctu) View more | - | 24 Jun 2013 |